Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A渋谷 高級デリヘル - アネモネ渋谷店
Malware Scan Info
Macafee Check :
Email address with anemia-treatment-hcp.com
Recent Searched Sites
Wiki.faked.org (37 seconds ago) / DE
Ccepde.org (42 seconds ago) / US
Maariv.co.il (6 seconds ago) / US
Ds7gaming.com (3 mins ago) / US
Afribaba.ug (38 seconds ago) / NL
Biozoneinternational.com (39 seconds ago) / US
Wordtracker.com (3 mins ago) / US
Procomponents.ant.design (36 seconds ago) / US
Dang.sasgujarat.in (39 seconds ago) / IN
Incod.ru (36 seconds ago) / RU
360.prompto.com (56 seconds ago) / US
Satvagold.com (45 seconds ago) / US
Katapengantar.my.id (20 seconds ago) / US
Hpprinters.net (1 mins ago) / US
Generaltech.ae (1 mins ago) / US
Atmsolutionsllc.com (50 seconds ago) / US
Anemia-treatment-hcp.com (0 seconds ago) / US
Tet.lv (23 seconds ago) / LV
Biozonescientific.com (8 seconds ago) / US
Asistencija.hak.hr (50 seconds ago) /
Domain Informations
Anemia-treatment-hcp.com lookup results from whois.corporatedomains.com server:
- Domain created: 2022-03-10T16:20:40Z
- Domain updated: 2024-03-06T06:07:56Z
- Domain expires: 2025-03-10T16:20:40Z 0 Years, 316 Days left
- Website age: 2 Years, 48 Days
- Registrar Domain ID: 2680594814_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.BMS.COM
- NS2.BMS.COM
- NS3.BMS.COM
- NS4.BMS.COM
Network
- inetnum : 165.89.0.0 - 165.89.255.255
- name : BMS-NET2
- handle : NET-165-89-0-0-1
- status : Direct Allocation
- created : 2021-11-15
- changed : 2023-08-16
Owner
- organization : Bristol-Myers Squibb Company
- handle : BRISTO-15-Z
- address : Array,New York,NY,10016,US
Technical support
- handle : TROIA3-ARIN
- name : Troiano, Lisa
- phone : +1-609-419-5475
- email : [email protected]
Abuse
- handle : BMSAB-ARIN
- name : BMS-ABUSE
- phone : +1-800-332-2056
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 680223 |
namecheap.com | 223695 |
networksolutions.com | 165349 |
tucows.com | 138518 |
publicdomainregistry.com | 89312 |
whois.godaddy.com | 62138 |
enomdomains.com | 58843 |
namesilo.com | 49234 |
cloudflare.com | 47031 |
gmo.jp | 46050 |
register.com | 39345 |
fastdomain.com | 38711 |
ionos.com | 33722 |
name.com | 32734 |
wildwestdomains.com | 32385 |
net.cn | 31518 |
registrar.amazon.com | 29951 |
key-systems.net | 27072 |
domains.google.com | 27061 |
Host Informations
Host name | 165.89.235.20 |
IP address | 165.89.235.20 |
Location | Trenton United States |
Latitude | 40.2187 |
Longitude | -74.7404 |
Metro Code | 504 |
Timezone | America/New_York |
Postal | 08629 |
Port Scanner (IP: 165.89.235.20)
Spam Check (IP: 165.89.235.20) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with anemia-treatment-hcp.com on Search Engine
HCP Information - FeraMAX® Pd
Oral iron supplement for the treatment of iron deficiency anemia. SYMPTOMS TRACKER Order F era max ® ... If you suspect iron deficiency, talk to an HCP. Ask your HCP if Fera max ® is right for you and take as directed. This product may not be right for you. Always read and follow the label. If you suspect iron deficiency, talk to a health care provider and ask whether FeraMAX® …
Feramax.comDA: 15 PA: 17 MOZ Rank: 32
Thalassemia Treatment: Training for Healthcare Providers …
Program Description. The thalassemia syndromes are a group of hereditary disorders in the synthesis of hemoglobin that result in varying degrees of anemia. Treatment for severe cases typically includes red blood cell transfusion and iron chelation therapy. Management of thalassemia is complex and may present many challenges to overcome.
Cdc.govDA: 11 PA: 50 MOZ Rank: 62
Anemia Treatments Underused in Non-Dialysis CKD | Boltz Research
According to investigators presenting at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference, only a subset of patients with nondialysis-dependent chronic kidney disease (NDD-CKD) initiate anemia medication despite clinical signs indicating treatment. “These longitudinal data support the concept that anemia is suboptimally managed among …
Boltzresearch.comDA: 21 PA: 50 MOZ Rank: 82
Home | Amgen ESA | HCP
EPOGEN ® (epoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis to decrease the need for red blood cell (RBC) transfusion.. Limitations of Use: ARANESP ® and EPOGEN ® have not been shown to improve quality of life, fatigue, or patient well-being.; ARANESP ® and EPOGEN ® are not indicated for use as a …
Amgenesas.comDA: 17 PA: 17 MOZ Rank: 21
Welcome to myAgios | Patient Support Services for HCPs
Avoid abruptly discontinuing PYRUKYND. Gradually taper the dose of PYRUKYND to discontinue treatment if possible. When discontinuing treatment, monitor patients for signs of acute hemolysis and anemia including jaundice, scleral icterus, dark urine, dizziness, confusion, fatigue, or shortness of breath.
Pyrukynd.myagios.comDA: 20 PA: 4 MOZ Rank: 28
Support and Services | Amgen ESA | HCP
EPOGEN ® (epoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis to decrease the need for red blood cell (RBC) transfusion.. Limitations of Use: ARANESP ® and EPOGEN ® have not been shown to improve quality of life, fatigue, or patient well-being.; ARANESP ® and EPOGEN ® are not indicated for use as a …
Amgenesas.comDA: 17 PA: 21 MOZ Rank: 43
Hemolytic Anemia treatment near Palo Alto, CA - WebMD
Hemolytic Anemia treatment near Palo Alto, CA 1,093 Results. SORT / FILTER . Featured Results; LM. LM. Dr. Lori Muffly, MD. Hematology. 0. 15 Years Experience . 15 Years Exp . 900 Blake Wilbur Dr, Palo Alto, CA 94304 3.31 miles . Dr. Muffly graduated from the Jefferson Medical College of Thomas Jefferson University in 2007. Dr. Muffly works in Palo Alto, CA and …
Doctor.webmd.comDA: 16 PA: 50 MOZ Rank: 80
Anemia: Causes and Types, Symptoms & Treatment - CPR Class
In men, it is considered anemia when hemoglobin level is below 13.5 gram/100 mL, whereas anything below 12.0 gram/100 mL is anemia for women. There are many different types of anemia which can occur to people. It is sometimes accompanied by certain symptoms, but can also be asymptomatic. Treatment varies on the specific cause, and thus can vary greatly for …
Cprclass.caDA: 11 PA: 44 MOZ Rank: 62
Depression – Cirrhosis Care
Biological: anemia, uremia, neurotoxins and possibly inflammation; Comorbidities: diabetes, cardiovascular disease Functional impairment: due to pain, dyspnea, edema or increased abdominal girth, as well as comorbidities such as dementia; Treatment-related: medications, pain, fatigue, discomfort, personal or family history of mood disorders Psychological: difficulty …
Cirrhosiscare.caDA: 16 PA: 50 MOZ Rank: 76
Enrollment | myAgios | HCP Website
Acute Hemolysis: Acute hemolysis with subsequent anemia has been observed following abrupt interruption or discontinuation of PYRUKYND in a dose-ranging study. Avoid abruptly discontinuing PYRUKYND. Gradually taper the dose of PYRUKYND to discontinue treatment if possible. When discontinuing treatment, monitor patients for signs of acute ...
Pyrukynd.myagios.comDA: 20 PA: 15 MOZ Rank: 44
Elderly - FeraMAX® Pd
Oral iron supplement for the treatment of iron deficiency anemia. SYMPTOMS TRACKER Order F era max ® ... If you suspect iron deficiency, talk to an HCP. Ask your HCP if Fera max ® is right for you and take as directed. This product may not be right for you. Always read and follow the label. If you suspect iron deficiency, talk to a health care provider and ask whether FeraMAX® …
Feramax.comDA: 15 PA: 25 MOZ Rank: 50
Kidney Disease and Iron Deficiency - FeraMAX® Pd
This causes your red blood cell count to drop and anemia to develop. Almost all patients suffering from stage 5 kidney disease are anemic. For those with chronic renal disease, the treatment of anemia is imperative. Anemia can be defined as an insufficient level of red blood cells, hemoglobin, and/or hematocrit in the body.
Feramax.comDA: 15 PA: 50 MOZ Rank: 78
What to Consider When Switching MS Treatments - Rebif
In controlled clinical trials, leukopenia occurred at a higher frequency in Rebif-treated patients than in placebo and Avonex-treated patients. Thrombocytopenia and anemia occurred more frequently in 44 mcg Rebif-treated patients than in placebo-treated patients. Monitor patients for symptoms or signs of decreased blood counts. Monitoring of ...
Rebif.comDA: 13 PA: 41 MOZ Rank: 66
HIGHLIGHTS OF PRESCRIBING INFORMATION
Epogen is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressivechemotherapy, and upon initiation,there is a minimum of two additional months of planned chemotherapy. 1.4 Reduction of Allogeneic Red Blood Cell Transfusionsin Patients Undergoing Elective, Noncardiac, …
Pi.amgen.comDA: 16 PA: 50 MOZ Rank: 37
My MISSION Support Program | HCP | MONJUVI® (tafasitamab-cxix)
MONJUVI can cause serious or severe myelosuppression, including neutropenia, thrombocytopenia, and anemia. Monitor complete blood counts (CBC) prior to administration of each treatment cycle and throughout treatment. Monitor patients with neutropenia for signs of infection. Consider granulocyte colony-stimulating factor administration. Withhold MONJUVI …
Mymissionsupport.comDA: 24 PA: 4 MOZ Rank: 42
JakatrO Risk for thrombocytopenia, anemia, and neutropenia
Patients developing anemia may require blood transfusions and/or dose modifications of Jakafi 9Severe neutropenia (ANC <0.5 × 10 /L) was generally reversible by withholding Jakafi until recovery hcp.Jakafi.com a Category 1: based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Incytevirtualbooth.comDA: 26 PA: 50 MOZ Rank: 35
Patient Support Services | myAgios | HCP Website
Acute Hemolysis: Acute hemolysis with subsequent anemia has been observed following abrupt interruption or discontinuation of PYRUKYND in a dose-ranging study. Avoid abruptly discontinuing PYRUKYND. Gradually taper the dose of PYRUKYND to discontinue treatment if possible. When discontinuing treatment, monitor patients for signs of acute hemolysis and …
Pyrukynd.myagios.comDA: 20 PA: 20 MOZ Rank: 56
How to Manage Anemia From HCV Treatment | Clinician Reviews
Major finding: In a study of 500 patients with chronic hepatitis C patients who developed anemia while on triple therapy, the sustained virologic response rates were similar among those who were managed with a reduced ribavirin dose (71.5%) and those who were treated with erythropoietin (70.9%). Data source: The randomized open-label multicenter study …
Mdedge.comDA: 14 PA: 50 MOZ Rank: 33
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
exponentialvelocitycommerce.com | domains2.squarespace.com | 257 Days |
professional-troublemaker.com | godaddy.com | 337 Days |
nunyadigital.com | xinnet.com | 117 Days |
typj.net | net.cn | 56 Days |
alikaranfil.com | onlinenic.com | 297 Days |
innovapes.net | godaddy.com | 1 Year, 1 Day |
hexawebony.com | publicdomainregistry.com | 26 Days |